Research

Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients with SMA

January 22, 2019
Posted in , ,

Cytokinetics, Incorporated (CYTK) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) that the Six Minute Walk Test (6MWT) […]

Read More ›

Genentech, Roche and PTC Therapeutics Provide Update on Regulatory Filing for Risdiplam

January 7, 2019
Posted in , ,

On January 7th, PTC Therapeutics, Inc. provided a corporate update, which will be detailed as part of the company’s presentation at the 37th Annual J.P. […]

Read More ›

Teen and Young Adult Survey Extended Through January 21st

January 7, 2019
Posted in , ,

Are you or a family member between the ages of 12 and 25? Do you want to share your opinion on living with SMA and […]

Read More ›

Cure SMA Announces Expanded Phase 3 of SMA Industry Collaboration

January 2, 2019
Posted in , ,

Cure SMA is pleased to announce the launch of an expanded Phase 3 of our SMA Industry Collaboration. The SMA Industry Collaboration is a multi-faceted […]

Read More ›

December Webinar on SMA Treatments and Clinical Trials Now Available Online

December 26, 2018
Posted in , ,

A recording of the December 13th webinar updating the community on SMA treatments and clinical trials is now available online. A PDF of the webinar […]

Read More ›

2018 Research Year-in-Review

December 21, 2018
Posted in , ,

Over our past fiscal year—from July 1, 2017, to June 30, 2018—Cure SMA has funded over $5 million in new research funding. This funding will be […]

Read More ›

Cure SMA Funding Leads to 16 New Research Publications in 2018

December 19, 2018
Posted in , ,

An important goal of our research funding strategy is to share scientific findings with the broader scientific community. Scientists who receive Cure SMA funding often […]

Read More ›

Biogen Issues Q4 Community Statement on Spinraza

December 13, 2018
Posted in , ,

Bigoen has provided the below community statement on Spinraza.  Dear Members of the SMA community, As we approach the two-year anniversary of the U.S. Food […]

Read More ›

AveXis Issues Community Statement on BLA Acceptance

December 12, 2018
Posted in , ,

AveXis has provided the following community statement on the BLA submission and acceptance for their investigational therapy, AVXS-101 – now known as ZOLGENSMA®. Dear SMA […]

Read More ›

Fall 2018 Issue of Compass Now Available

December 4, 2018
Posted in , , ,

The fall 2018 issue of Compass is now available online. This issue of Compass covers the SMA Care Center Network and its goal of developing an […]

Read More ›
Scroll to Top